Amryt Pharma (AMYT)

Sector:

Financials

Index:

FTSE AIM All-Share

 198.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 218.00p
  • 52 Week Low: 90.00p
  • Currency: UK Pounds
  • Shares Issued: 162.80m
  • Volume: 7,594
  • Market Cap: 322.35m

Amryt Pharma Overview

Amryt Pharma is in the financials sector and is currently trading at 198.00p per share. In the last year Amryt Pharma's share price has ranged from 90.00p to 218.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -92.5% -37.7%
ROCE 123.8%  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 7.4 2.4
Pr/Book 3.3  
Latest F'cast
Revenue 240.0% 75.1%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Amryt Pharma Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-15 n/a (1.19) (12.84)¢ n/a n/a n/a n/a 0.0%
31-Dec-16 1.35 (7.80) (28.68)¢ n/a n/a n/a n/a 0.0%
31-Dec-17 12.78 (26.14) (70.32)¢ n/a n/a n/a n/a 0.0%
31-Dec-18 17.09 (30.44) (402.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-19 58.12 (66.76) (86.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Amryt Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 135.74 (51.16) (10.02)p n/a n/a n/a n/a 0.0%
31-Dec-21 152.84 (30.59) (4.64)p n/a n/a n/a n/a 0.0%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Amryt Pharma Company Announcements

Amryt Reports Record Q3 2020 Results - Raising F... 05-Nov-2020 12:00 GlobeNewswire NA
AMRYT ANNOUNCES POSITIVE RESULTS FROM PHASE 3 TR... 29-Oct-2020 07:00 GlobeNewswire NA
Amryt and Swixx Sign Distribution Deal for Lojuxta 19-Oct-2020 07:00 GlobeNewswire NA

Latest Amryt Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Amryt Pharma Market Data

Currency UK Pounds
Share Price 198.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 218.00p
52 Week Low 90.00p
Volume 7,594
Shares Issued 162.80m
Market Cap 322.35m

Amryt Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
42.28% below the market average42.28% below the market average42.28% below the market average42.28% below the market average42.28% below the market average
40.15% below the sector average40.15% below the sector average40.15% below the sector average40.15% below the sector average40.15% below the sector average
Price Trend
92.32% above the market average92.32% above the market average92.32% above the market average92.32% above the market average92.32% above the market average
93.06% above the sector average93.06% above the sector average93.06% above the sector average93.06% above the sector average93.06% above the sector average
Income Not Available
Growth
66.37% above the market average66.37% above the market average66.37% above the market average66.37% above the market average66.37% above the market average
69.11% above the sector average69.11% above the sector average69.11% above the sector average69.11% above the sector average69.11% above the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Amryt Pharma Dividends

No dividends found

Trades for 30-Nov-2020

Time Volume / Share Price
16:35 910 @ 198.00p
15:04 2,833 @ 196.00p
13:45 500 @ 198.00p
12:46 218 @ 198.00p
12:23 500 @ 196.00p

Amryt Pharma Key Personnel

CEO Joe Wiley
CFO Rory Nealon

Top of Page